IDEXX Laboratories Now Offers Cancer Testing Features for Dogs in the UK
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announced the availability of the IDEXX Cancer Dx Panel in the United Kingdom on 1st April, 2026, beginning with early detection of lymphoma in at-risk dogs. The blood test can be added to panels for sick pets and integrated into regular wellness screenings, […]
